TG Therapeutics, Inc.

TGTX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Period	Revenue	Operating Income	Net Income
Jun 2010	—	$-525.1K	$1.9M
Sep 2010	—	$-515.6K	$41.2K
Jun 2011	—	$-297.0K	$-282.1K
Sep 2011	—	$-30.1K	$-28.6K
Mar 2012	—	$-17.4M	$-10.3M
Jun 2012	—	$-3.1M	$-1.9M
Sep 2012	—	$-2.7M	$-2.5M
Dec 2012	—	$-3.7M	$-3.5M
Mar 2013	—	$-3.7M	$-3.7M
Jun 2013	—	$-6.6M	$-6.6M
Sep 2013	—	$-4.6M	$-4.6M
Dec 2013	—	$-8.0M	$-5.7M
Mar 2014	—	$-7.6M	$-7.5M
Jun 2014	—	$-12.0M	$-12.0M
Sep 2014	—	$-17.4M	$-17.5M
Dec 2014	—	$-18.7M	$-18.8M
Mar 2015	—	$-14.6M	$-14.6M
Jun 2015	—	$-17.1M	$-17.1M
Sep 2015	—	$-13.8M	$-13.7M
Dec 2015	—	$-17.6M	$-17.6M
Mar 2016	—	$-14.0M	$-13.8M
Jun 2016	—	$-16.0M	$-15.9M
Sep 2016	—	$-24.9M	$-24.8M
Dec 2016	—	$-24.0M	$-23.7M
Mar 2017	—	$-27.7M	$-27.7M
Jun 2017	$38.0K	$-28.4M	$-28.4M
Sep 2017	$38.0K	$-31.6M	$-31.5M
Dec 2017	—	$-31.0M	$-30.9M
Mar 2018	$38.0K	$-41.6M	$-41.5M
Jun 2018	$38.0K	$44.3M	$-44.1M
Sep 2018	$38.0K	$-34.3M	$-34.0M
Dec 2018	$38.0K	$-142.8M	$-53.9M
Mar 2019	$38.0K	$-34.7M	$-35.2M
Jun 2019	$38.0K	$-35.5M	$-36.2M
Sep 2019	$38.0K	$-60.9M	$-61.9M
Dec 2019	$38.0K	$-38.0M	$-39.6M
Mar 2020	$38.0K	$-50.2M	$-51.1M
Jun 2020	$38.0K	$-50.8M	$-52.9M
Sep 2020	$38.0K	$-85.7M	$-87.2M
Dec 2020	$38.0K	$-86.8M	$-88.2M
Mar 2021	$793.0K	$-89.2M	$-90.6M
Jun 2021	$1.5M	$-77.5M	$-78.5M
Sep 2021	$2.0M	$-85.1M	$-85.6M
Dec 2021	$2.3M	$-92.9M	$-93.3M
Mar 2022	$2.0M	$-66.9M	$-69.0M
Jun 2022	$594.0K	$-38.9M	$-40.5M
Sep 2022	$94.0K	$-35.0M	$-35.8M
Dec 2022	$81.0K	$-77.5M	$-78.5M
Mar 2023	$7.8M	$-37.0M	$-39.2M
Jun 2023	$16.1M	$-44.7M	$-47.6M
Sep 2023	$165.8M	$114.8M	$113.9M
Dec 2023	$44.0M	$-12.5M	$-14.4M
Mar 2024	$63.5M	$-9.3M	$-10.7M
Jun 2024	$73.5M	$8.8M	$6.9M
Sep 2024	$83.9M	$12.4M	$3.9M
Dec 2024	$108.2M	$29.9M	$23.3M
Mar 2025	$120.9M	$8.6M	$5.1M
Jun 2025	$141.1M	$34.8M	$28.2M
Sep 2025	$161.7M	$29.4M	$390.9M
Dec 2025	$192.6M	$50.5M	$23.0M
Mar 2026	$204.9M	$34.8M	$19.8M
Jun 2026	$240.3M	$21.7M	$7.8M